ChemoCentryx (CCXI) Stock Is Climbing: Here’s Why

ChemoCentrix CCXI Stock News

ChemoCentryx Inc (NASDAQ: CCXI) is screaming for the top in the market today, gaining momentum after yesterday’s more than 3% gains. The gains come after a massive decline in share values in May as investors see what could become a discounted opportunity to get in on future gains. However, there are major concerns to consider … Read more

ChemoCentrix (CCXI) Stock Could Make A Huge Comeback

ChemoCentrix CCXI Stock News

ChemoCentryx Inc (NASDAQ: CCXI) is headed for the top in the market this morning, making up for some of the dramatic declines seen on the stock Friday after a panel of experts was mixed with regard to an approval recommendation for the company’s autoimmune disease drug candidate.  Nonetheless, Wall Street Bets members, and members of … Read more

ChemoCentryx (CCXI) Stock: Gaining After Terminating Public Offering

ChemoCentryx Inc (NASDAQ: CCXI) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it will not be moving forward with a previously announced public offering of common stock. With the dilutive offering off of the table, investors are excited and pushing the stock toward … Read more

Viking Therapeutics (VKTX) Stock: Leading The Biotech Sector Today

Viking Therapeutics Inc (NASDAQ: VKTX) is the leader among biotechnology stocks today after the company released positive top-line data from a Phase 2 clinical study. The study was designed to assess VK2809, the company’s candidate for the treatment of NAFLD. NAFLD is a severe condition with serious unmet medical need, so the positive data is … Read more

ChemoCentryx (CCXI) Stock: Climbs As Vifor Increases Stake

cChemoCentryx Inc (NASDAQ: CCXI) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that Vifor Pharma Group has increased its stake in the comapny, exciting investors who are sending the stock on a run for the top. Today, we’ll talk about: The increased stake; what … Read more

ChemoCentrix (CCXI) Stock: Halted! We’re Keeping Tabs On The Story

ChemoCentryx Inc (NASDAQ: CCXI) ChemoCentryx wasn’t off to the best of days in the market today. When the opening bell rang, the stock found itself in the red. Throughout the day, we’ve seen relatively flat movement. However, minutes ago, our partners at Trade Ideas informed us that the stock has been halted. Below, we’ll talk … Read more

ChemoCentryx (CCXI) Stock Edges Up On PRIME Designation From EMA

ChemoCentryx Inc (NASDAQ: CCXI) ChemoCentryx is having a strong start to the trading day today, and for good reason. The company announced early this morning that it has received PRIME designation from the European Medicines Agency for one of its treatment candidates. Today, we’ll talk about the designation, how the market reacted to the news, … Read more

ChemoCentryx (CCXI) Stock More Than Doubles In Value: Here’s Why!

ChemoCentryx Inc (NASDAQ: CCXI) ChemoCentryx is having an incredible day in the market today. In fact, the stock has already more than doubled in value! The reason for the gain is simple – the company reported earnings and surprised investors with a collaboration. Today, we’ll talk about the details of the earnings report, how investors are … Read more